Our study identified two novel glycolysis-related genes (PKP2 and TSTA3) associated with the prognosis of rectal cancer patients, and further established a risk model based on two novel glycolysis-related genes to effectively predict the prognosis of rectal cancer patients. This evidence concerns the gene GFUS and rectal cancer.